Effects of OPC-6535 on lipopolysaccharide-induced acute liver injury in the rat: Involvement of superoxide and tumor necrosis factor-α from hepatic macrophages

Surgery

Volumn 134, Issue 5, 2003, Pages 818-826

  Hasegawa, Tadashi ^a   Sakurai, Kazushi ^b   Kambayashi, Yasuhiro ^b   Saniabadi, Abby R ^b   Nagamoto, Hisashi ^b   Tsukada, Katsuhiko ^b   Takahashi, Atsushi ^b   Kuwano, Hiroyuki ^b   Nakano, Minoru ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; MYELOPEROXIDASE; SUPEROXIDE; TETOMILAST; THIAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL FUNCTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HISTOCHEMISTRY; IN VIVO STUDY; LIVER INJURY; LIVER PERFUSION; MACROPHAGE; MALE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RAT;

EID: 0346874135     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(03)00297-6     Document Type: Article

References (29)

1. Hewett JA, Roth RA. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993;45: 381-411.
2. Ferluga J, Allison AC. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 1978;II:610-1.
3. Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993;104:1466-71.
4. Arthur MJP, Bentley IS, Tanner AR, Kowalski-Saunders P, Millward-Sadler GH, Wright R. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 1985; 89:1114-22.
5. Nagakawa J, Hishimura I, Hirota K, Miyamoto K, Yamanaka T, Tsukidate K, et al. Involvement of tumor necrosis factor-α in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990;99:758-65.
6. Iimuro Y, Yamamoto M, Kohno H, Itakura J, Fujii H, Matsumoto Y. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats - analysis of mechanisms of lethality in endotoxemia. J Leukoc Biol 1994;55:723-8.
7. Hasegawa T, Nakano M, Hashimoto T, Hiraishi K, Suzuki K, Kuwano H. Sinusoidal endothelial cell injury by superoxide anion and iron in the Propionibacterium acnes-pretreated and lipopolysaccharide-stimulated rat liver. Liver 2001;21:415-24.
8. Beutler B, Cerami A. The history, properties, and biological effects of cachectin. Biochemistry 1988;27:7575-82.
9. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579-85.
10. Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 1990;4:3215-23.
11. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
12. Baggiolini M, Clerk-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992;307:97-101.
13. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994;56:672-86.
14. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-7.
15. Chihiro M, Nagamoto H, Takemura I, Kitano K, Komatsu H, Sekiguchi K, et al. Novel thiazole derivatives as inhibitors of superoxide production by human neutrophils : synthesis and structure-activity relationship. J Med Chem 1995;38:353-8.
16. Bloomfield GL, Ridings PC, Blocher CR, Fisher BJ, Sugerman HJ, Nagamoto H, et al. OPC-6535, a superoxide anion production inhibitor, attenuates acute lung injury. J Surg Res 1997;72:70-7.
17. Cheng X-S, Shimokawa H, Momii H, Oyama J, Fukuyama N, Egashira K, et al. Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc Res 1999;42:651-9.
18. Ejiri S, Eguchi Y, Kishida A, Kurumi Y, Tani T, Kodama M. Protective effect of OPC-6535, a superoxide anion production inhibitor, on liver grafts subjected to warm ischemia during porcine liver transplantation. Transplant Proc 2000;32:318-21.
19. Hasegawa T, Kikuyama M, Sakurai K, Kambayashi Y, Adachi M, Saniabadi AR, et al. Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. Liver 2002;22:321-9.
20. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. Methods Enzymol 1990;186:585-91.
21. Ogata I, Mochida S, Fujiwara K. Formazan formation in hepatic macrophages after nitro blue tetrazolium perfusion into rat liver. Biomed Res 1988;9:113-7.
22. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation : estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
24. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2-5.
25. Oshita M, Takei Y, Kawano S, Hijioka T, Masuda E, Goto M, et al. Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver. Hepatology 1994;20:961-5.
26. Grisham MB, Jourd'heuil D, Wink DA. Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999;276: G315-21.
27. Thomas EL, Learn DB, Jefferson MM, Weatherred W. Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils. J Biol Chem 1988;263: 2178-86.
28. Kettle AJ, Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 1988;252:529-36.
29. Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med 2001;30: 287-98.